Google
Trusted Resources: News & Meetings
Latest announcements and gatherings
Matt Millen, in Remission but Facing More Treatment, Plans TV Return This Fall
Matt Millen plans to return to the broadcast booth this fall, beginning with Penn State’s season opener in September, as he continues being treated for amyloidosis, a rare disease that eventually will require him to undergo a heart transplant. The Big Ten Conference was happy to hear that.
“He’s just an inspiration in how he handles himself and how he’s handled his sickness,” said Mark Silverman, president of the Big Ten Network, for whom Millen is the lead analyst. “He wants to work. He doesn’t complain. Your heart goes out to him for his recovery, as best he can, and we want to do all we can to help him. He’s been really important for us.”
Millen, the Whitehall High and Penn State graduate, attended this week’s Big Ten media days, where coaches, administrators and fellow broadcasters welcomed his return. Millen completed his most recent course of chemotherapy eight weeks ago, saying Tuesday that he feels stronger and has more stamina than he did last spring.
myBinderRelated Content
-
Michael York Talks About His Personal Battle With Amyloidosis and Stem Cell Researchhttps://www.youtube.com/watch?v=_cF0pY9I...
-
Mackenzie’s MissionWhy Mackenzie’s Mission As a result o...
-
New Miami Hurricanes DL Coach Todd Stroud has Overcome Life Threatening IllnessNew Miami Hurricanes defensive line coac...
-
Muriel FinkelMuriel Finkel is the President of Amyloi...
-
My Diagnosis Doesn’t Make Sense – Amyloidosishttps://www.youtube.com/watch?v=rtWDjZeM...
-
After Treatment for Serious Illness, NBC-5 Anchor Rob Stafford Returning to AirNBC-5 News anchor Rob Stafford will retu...
-
Gregory Foster AL Amyloidosis “A Fight for Answers”https://www.youtube.com/watch?v=HkKTyKBr...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
